hCAIX/XII-IN-6 is a potent, orally bioavailable carbonic anhydrase inhibitor with high selectivity for tumor-associated isoforms hCA IX (Ki=4.1 nM) and XII (Ki=7.7 nM). It is used in rheumatoid arthritis research and has demonstrated efficacy in reducing disease severity in preclinical in vivo models of inflammation.
Molecular Weight:
601.74
Formula:
C26H23N3O6S4
Target:
Carbonic Anhydrase,Others
* VAT and and shipping costs not included. Errors and price changes excepted
